wellrank.ai
Clomid logo

Clomid

First cited by AI Jun 12, 2026
clomid.pro

Surfaced organically in AI answers about trt and men's health. Not yet profiled.

AI Visibility

Visibility trend

TRT and men's health, daily share of AI answers mentioning Clomid, through Jun 13, 2026.

8.3%

Avg position when mentioned: 8.0

By engine

Where Clomid is strong, and where it is invisible.

  • ChatGPT
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 3 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Clomid

ChatGPTJun 13, 2026, 11:03 UTC
What testosterone level is low enough to need treatment?

Short answer: most guidelines use a total testosterone cutoff of about 300 ng/dL (≈10.4 nmol/L). Treatment is usually considered only if you have consistent low measurements plus symptoms of testosterone deficiency. Details and what that means for you Typical adult male total testosterone reference is roughly 300–1,000 ng/dL (10.4–34.7 nmol/L), though lab ranges vary. The Endocrine Society and American Urology Association commonly use a threshold of ~300 ng/dL. If total testosterone is below ~300 ng/dL on at least two morning (7–10 a.m.) measurements and you have symptoms (low libido, erectile problems, low energy/mood, loss of muscle mass, increased body fat, anemia, decreased bone density), treatment may be appropriate. Very low values (for example <200 ng/dL) are much more likely to cause symptoms and to prompt treatment or urgent evaluation. Important caveats Measure testosterone in the morning, while fasting if possible, and repeat the test because illness, stress, some meds, and acute medical problems can transiently lower levels. If total testosterone is borderline (250–350 ng/dL) or if you have conditions that change SHBG (obesity, diabetes, liver disease, thyroid disease), free testosterone or calculated bioavailable testosterone should be checked — labs report different reference ranges, so compare to your lab’s normal values. You also need further testing to find the cause: LH/FSH (to distinguish primary vs secondary hypogonadism), prolactin, and sometimes iron studies, sleep apnea screen, and metabolic testing. When NOT to give therapy and other concerns Don’t start exogenous testosterone if you have suspected or active breast or prostate cancer. Other contraindications/precautions include very high hematocrit, uncontrolled heart failure, and some recent cardiovascular events — these need individualized discussion with a clinician. Exogenous testosterone suppresses sperm production and can cause infertility. If you want to preserve or build fertility, alternatives include clomiphene citrate (commonly used off‑label) or hCG — discuss with a specialist. Common treatment options (examples and why) Topical gels: AndroGel, Testim — steady daily dosing, easy to use, but risk of transfer to others. Transdermal patch: Androderm — steady delivery, once-daily patch. Intramuscular injections: testosterone cypionate/enantate (often dispensed as Depo-Testosterone or generic testosterone cypionate) — less expensive, given every 1–3 weeks; can cause peaks and troughs. Long‑acting injections (testosterone undecanoate: Aveed/Nebido) provide more stable levels but require specific administration. Nasal: Natesto — multiple daily doses, lower systemic exposure between doses for some people. Fertility-preserving therapies: clomiphene citrate (Clomid, off‑label in men) or hCG (Ovidrel or prescribed hCG products) to raise endogenous testosterone without suppressing spermatogenesis as much. Monitoring if you start therapy Regular follow‑up with serum testosterone (to target mid‑normal range), hematocrit (risk of polycythemia), PSA, lipids, liver tests as indicated, and assessment of symptoms. Next step See your primary care doctor, urologist, or endocrinologist. Ask for a morning total testosterone test (and repeat it if low), plus LH/FSH and prolactin if the result is low. If you want, tell me your lab number(s) and symptoms and I can help interpret them and outline likely next steps.

Mentioned in position 8 of 9

Read full answer with sources →
ChatGPTJun 12, 2026, 12:44 UTC
Can I stop TRT once I start or is it forever?

Short answer: Yes — you can stop testosterone replacement therapy (TRT). It is not necessarily forever. But what happens after you stop depends on why you needed TRT, how long and how much you’ve been using, and whether you care about fertility. What to expect if you stop Your testosterone levels fall back to whatever your body was producing (often within days–weeks). Symptoms (low energy, low libido, depressed mood, loss of muscle, etc.) usually return and can take weeks–months to stabilize. Fertility: exogenous testosterone suppresses LH/FSH and sperm production. Sperm counts commonly fall within months and can take 3–12+ months to recover (sometimes longer or incompletely) once you stop. Bone health and metabolism: long-term TRT helps maintain bone density; stopping long-term TRT can gradually reduce bone density — consider monitoring if you stop. Recovery of your own HPT axis: if you have primary testicular failure (e.g., Klinefelter’s, orchiectomy, chemo), your testes may not recover and TRT may be needed lifelong. If your hypogonadism is secondary (HPA/pituitary-related or medication-related), recovery is more likely, especially if TRT duration was short. Options and steps to take Talk with your prescriber (primary care, endocrinologist, or urologist) before stopping. They’ll review why you started TRT and plan safe discontinuation and follow‑up. If fertility is desired, don’t simply stop and hope for the best — ask about alternatives that preserve or restore sperm production, such as: hCG (human chorionic gonadotropin; e.g., Pregnyl, Novarel) to stimulate testosterone production while preserving spermatogenesis, Clomiphene citrate (Clomid) — a SERM that can raise endogenous testosterone and preserve fertility, Enclomiphene (Androxal in some places) — similar SERM option in selected patients. If you stop TRT, your clinician may monitor morning total testosterone, LH/FSH, estradiol, CBC (hematocrit), PSA (if appropriate), and consider a semen analysis if fertility is a concern. Typical check times: 4–8 weeks after stopping, then at 3–6 months depending on symptoms. Consider DEXA if bone health is a concern. If you have been on TRT long-term or high doses, recovery may be slower; some clinicians use a short course of hCG or clomiphene to speed recovery of the axis. Common TRT products (so you know what you were using) Injectable: testosterone cypionate (Depo-Testosterone) or enanthate (often generic). Topical gels/solutions: AndroGel, Testim, Axiron. Nasal: Natesto (short-acting nasal gel). Long-acting intramuscular: Aveed (requires clinic administration). Different formulations have different pharmacology and fertility impacts; discuss switching formulations only with your clinician. Who to see Endocrinologist or urologist with men’s health experience for complicated cases. Male infertility or reproductive endocrinology clinics if fertility is important. If you used a commercial telehealth TRT service (e.g., Hims, Roman, Ro), contact them to arrange a supervised discontinuation and follow-up, but consider getting an in-person specialty consult for fertility or complex recovery. Bottom line You can stop TRT, but do it with medical guidance. If your hypogonadism is permanent (primary testicular failure) you may need ongoing TRT; if it’s reversible or secondary, your body may recover but that can take months and is not guaranteed. If you want children, talk to your provider first — there are specific treatments (hCG, clomiphene) that better preserve or restore fertility than standard TRT. If you want, tell me why you started TRT (reason, how long you’ve been on it, type/dose, whether you want children) and I can give more tailored guidance on what to expect and next steps.

Mentioned in position 3 of 13

Read full answer with sources →
ChatGPTJun 12, 2026, 12:42 UTC
Enclomiphene vs TRT: which should I consider first?

Short answer If you want to preserve or improve fertility (or sperm count) and your problem looks like secondary/functional hypogonadism (low T with low/normal LH/FSH): try a SERM that boosts your own testosterone first — enclomiphene (or the commonly used alternative clomiphene/Clomid) is appropriate. If you have primary testicular failure (high LH/FSH), need faster/stronger symptom control, or definitely don’t want future fertility, testosterone replacement therapy (TRT) is usually the better choice. Why they differ (brief) Enclomiphene: a SERM that raises GnRH→LH/FSH → stimulates the testes to make more testosterone. It usually preserves or increases sperm production and is useful for secondary hypogonadism. Response takes weeks to months. TRT: supplies exogenous testosterone (gels, injections, pellets). It reliably raises serum T and often relieves symptoms faster, but suppresses LH/FSH and usually reduces sperm count (can cause infertility) and has other risks (polycythemia, PSA changes, etc.). When to consider enclomiphene first You want to maintain or improve fertility. Your labs show low morning total T with low/normal LH and FSH (suggests central/functional hypogonadism). You prefer an oral medication (or to avoid injections/gel) and are willing to wait weeks for effect. You and your clinician accept off-label/limited availability issues (see below). When TRT is more appropriate Primary hypogonadism (elevated LH/FSH) — testes cannot respond adequately. Severe symptoms needing faster effect, or long-term willingness to be infertile or use sperm preservation. Prior failure or intolerance of SERMs. Contraindications to SERMs or specific comorbidities favoring TRT after evaluation. Efficacy and side-effect highlights Enclomiphene/clomiphene: can increase endogenous T and maintain/increase sperm counts. Side effects: mood swings, possible changes in vision, increased estradiol/gynecomastia in some men; thrombosis risk is small but theoretical. TRT: increases T reliably; side effects include erythrocytosis (monitor hematocrit), acne/oily skin, testicular shrinkage and infertility, possible PSA rise — cardiovascular risk is debated and should be individualized. Availability and brands/services (names to discuss with your clinician) Enclomiphene: frequently discussed as Androxal in literature — availability can be limited; many clinicians use clomiphene citrate (Clomid) off-label for men because it’s widely available and inexpensive. TRT products: gels (AndroGel, Testim, Fortesta), intramuscular injections (Depo‑Testosterone/testosterone cypionate; Aveed/testosterone undecanoate), pellets (Testopel). Telehealth/men’s clinics that often prescribe TRT (for convenience, not a replacement for specialist care): Roman, Hims, Vault Health — if fertility or diagnostic uncertainty is present, see an endocrinologist or urologist with reproductive experience instead. Important next steps (practical) Get proper baseline labs: two morning total testosterone measurements (preferably 7–10 AM) on different days, LH, FSH, prolactin, estradiol, CBC, CMP, and PSA if >40 or prostate risk. Review symptoms and fertility plans with an endocrinologist or urologist (or reproductive specialist if fertility is important). If secondary hypogonadism and fertility desired → consider enclomiphene or clomiphene trial with monitoring of T and semen analysis. If primary hypogonadism or fertility not desired → discuss TRT options, dosing, and monitoring (hematocrit, PSA, T levels). If you want, I can: Help interpret your lab results if you share them (with morning times). Outline a monitoring schedule for either an enclomiphene/clomiphene trial or TRT. Summarize pros/cons of specific TRT formulations for your lifestyle (gels vs injections vs pellets). Remember: the right choice depends on your labs, symptoms, fertility goals, and medical history — discuss options with a clinician before starting treatment.

Mentioned in position 2 of 11

Read full answer with sources →

Public AI visibility history

Daily rank of Clomid on our buyer intent questions, per category. A dash means the engines did not cite Clomid at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
TRT and men's health#35#30

TL;DR

Clomid is the brand name for clomiphene citrate, a selective estrogen receptor modulator originally approved for ovulation induction in women but widely used off-label in men to stimulate endogenous testosterone production. The domain clomid.pro appears to be an informational or telehealth-adjacent resource surfacing around this medication. In WellRank's latest index it ranks tenth in TRT and men's health AI answers, capturing 8% visibility, with all three recorded AI mentions carrying a neutral tone.

Company Overview

Clomid as a pharmaceutical product was originally developed and marketed by Sanofi, though the clomid.pro web presence operates as an independent informational or telehealth-affiliated platform rather than the originating manufacturer. The site appears to serve visitors researching clomiphene citrate for men's hormonal health, functioning as a content and possibly referral resource within the direct-to-consumer telehealth space. Founding details and corporate structure for the clomid.pro entity specifically are not publicly disclosed.

Product Features

  • Clomiphene citrate (Clomid) information for off-label male hypogonadism and low testosterone
  • Educational content on stimulating natural testosterone production via LH and FSH pathways
  • Comparison guidance positioning clomiphene against traditional TRT protocols
  • Information on fertility preservation as an advantage over exogenous testosterone
  • Content addressing dosing considerations and monitoring for men using clomiphene

Target Market

The primary audience is men experiencing symptoms of low testosterone or hypogonadism who are exploring alternatives to exogenous testosterone replacement therapy, particularly those concerned about fertility preservation. The content also reaches men researching post-cycle therapy after anabolic steroid use. Geography is not publicly specified but the site is in English and oriented toward a North American audience.

Buyer Personas

  • A man in his late 20s to 40s with clinically low testosterone who wants to preserve fertility while addressing hormonal symptoms.
  • A bodybuilder or fitness enthusiast researching clomiphene as a post-cycle therapy option after a steroid cycle.
  • A middle-aged man who has been offered TRT by his doctor but wants to understand non-exogenous alternatives before committing.
  • A health-conscious consumer comparison-shopping telehealth TRT options and seeking independent educational resources.

Funding & Performance

Funding, valuation, and ownership details for the clomid.pro entity are not publicly disclosed. Clomid as a pharmaceutical compound is an established generic medication available worldwide, so the underlying drug is not venture-backed in any startup sense.

Recent Developments

Interest in clomiphene citrate for male hypogonadism has grown steadily as the men's health telehealth sector has expanded, and clomid.pro appears to have positioned itself to capture organic search and AI-answer traffic in this space. The broader conversation around alternatives to traditional TRT, including compounds like Androxal (enclomiphene, a refined isomer of clomiphene), has kept clomiphene-related content relevant. No specific product launches or company announcements for this domain are publicly known.

Competitive Landscape

In WellRank's co-mention data, Clomid surfaces alongside established testosterone therapies such as AndroGel, Testim, Depo-Testosterone, Aveed, and Natesto, as well as telehealth platforms like Roman and specialty providers like Vault Health. Androxal is a particularly close conceptual competitor as it is a purified enclomiphene isomer targeting the same pathway. Unlike gel and injectable products, clomiphene's appeal is its oral administration and fertility-sparing mechanism, which differentiates it in a crowded TRT market.

Clomid vs the brands AI recommends alongside it

The real competitive set in TRT and men's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Clomid logo
ClomidThis brand
#30
8.3%
AndroGel logo
AndroGel

3 shared answers

#21
8.3%
Aveed logo
Aveed

3 shared answers

#26
8.3%
Depo-Testosterone logo
Depo-Testosterone

3 shared answers

#25
8.3%
Testim logo
Testim

3 shared answers

#22
8.3%

Email me when overtakes Clomid

One email the day the ranks flip. Nothing else.

User Sentiment

According to WellRank's corpus, all three AI mentions of Clomid in the TRT and men's health category carry a neutral tone, with zero positive or cautious mentions recorded. This reflects how AI engines tend to treat clomiphene: as a factually documented, clinically recognized option discussed objectively rather than enthusiastically promoted. Public forums and men's health communities show genuine interest in clomiphene as a TRT alternative, though discussions frequently note its off-label status for men and the importance of physician oversight.

Pricing

Clomiphene citrate is a generic medication and its cost varies significantly depending on pharmacy, insurance coverage, and whether it is obtained through a telehealth platform or a traditional prescription. Pricing through telehealth providers is not published in any standardized way, and out-of-pocket costs for the generic drug at retail pharmacies can differ widely by region and supplier.

Sources cited around Clomid

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Clomid weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Clomid? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.